The 5 mistakes GLP-1 users make with reconstitution

Why reconstitution gets almost no coverage

There is an information vacuum around peptide reconstitution, and it exists for a specific, structural reason. Major health publishers — WebMD, Healthline, Mayo Clinic, Cleveland Clinic — will not publish detailed reconstitution guides. The reason is liability. Publishing step-by-step instructions for reconstituting and self-injecting a compounded peptide implies endorsement of a practice that sits in a regulatory gray zone. Their legal teams will not approve it. Their medical review boards will not sign off. So the content simply does not get written by the institutions that have the editorial rigor to get it right.

What fills the gap is predictable. Peptide vendors publish reconstitution guides on their websites and YouTube channels. These guides are sometimes accurate. They are never disinterested. The company selling you the lyophilized semaglutide analog also sells the bacteriostatic water, the insulin syringes, the alcohol swabs, and the sharps containers. Their incentive is to make the process sound easy and approachable — to reduce purchase friction, not to reduce your risk. They will not dwell on contamination timelines. They will not walk you through the math slowly enough for you to catch a factor-of-ten error. They will not tell you when to throw a vial away, because every discarded vial is a vial you need to reorder.

Reddit and peptide forums fill the remaining space. The information there ranges from meticulous to dangerous, and distinguishing between the two requires the very expertise a new user does not yet have. A highly upvoted post from someone with “years of experience” may contain a reconstitution protocol that a compounding pharmacist would reject on three separate grounds.

This matters because dosing errors from reconstitution mistakes are probably the single biggest avoidable risk in the compounded GLP-1 space. Not the peptide purity. Not the injection technique. The moment where you add liquid to powder and decide how much to draw into a syringe — that is where the consequential errors happen. A bad reconstitution can mean injecting degraded peptide with reduced bioavailability, or injecting into a bacterially contaminated solution, or — most dangerously — injecting ten times the intended dose because the dilution math went wrong.

We do not sell peptides. We do not sell BAC water. We do not sell syringes. Our only incentive in writing this is accuracy. That distinction matters more than it should have to.

The anatomy of a lyophilized peptide vial

Before discussing what goes wrong, it helps to understand what you are working with. The vial in front of you contains a lyophilized peptide — freeze-dried, reduced to a fine white or off-white powder. Lyophilization is not simply dehydration. The peptide solution is first frozen, then placed under deep vacuum. The ice sublimates directly from solid to gas, bypassing the liquid phase entirely. What remains is a porous cake or powder of the peptide and its excipients.

Those excipients matter. Most lyophilized peptide formulations include a lyoprotectant — typically mannitol, sucrose, or trehalose. These sugars form a glassy matrix around the peptide molecules during the drying process, physically preventing the kind of structural collapse that would otherwise occur when the hydration shell is stripped away. When you look at the powder in the vial, you are seeing peptide molecules suspended in a sugar glass, frozen in their native conformation.

The reason peptides are sold in lyophilized form is stability. Peptide bonds in aqueous solution undergo hydrolysis over time — water molecules attack the amide bonds that link amino acids together, gradually cleaving the chain. The rate depends on pH, temperature, and the specific peptide sequence, but the trajectory is always the same: degradation. A reconstituted semaglutide analog in solution at refrigerator temperature will degrade measurably over weeks. The same peptide in lyophilized form, stored properly, remains stable for months to years.

Reconstitution reverses the lyophilization. You add a compatible aqueous vehicle — bacteriostatic water, in most cases — and the sugar glass dissolves, releasing the peptide molecules back into solution. The powder should dissolve completely, yielding a clear, colorless (or very faintly yellow, depending on the peptide) liquid. If it does not dissolve completely, something has gone wrong, and you need to understand why before proceeding.

The critical implication of all this: the moment you add liquid, the clock starts. You have converted a stable, solid-state formulation into an aqueous solution that is now subject to hydrolysis, microbial contamination, oxidation, and temperature-dependent degradation. Every decision you make from this point forward — what liquid you use, how you mix it, where you store it, how long you keep it — determines whether the peptide in your syringe three weeks later is the same molecule you started with.

Mistake 1: Using saline instead of bacteriostatic water

This is the most common substitution error, and it stems from a reasonable-sounding assumption: if saline is used for injections in hospitals, it must be fine for reconstituting peptides. It is not fine. The distinction is not about the saline itself — it is about what saline lacks.

Normal saline (0.9% sodium chloride) is an isotonic, sterile solution. It is packaged in single-use vials or bags, and it is intended to be used immediately after opening. It contains no preservative. No antimicrobial agent. Nothing that inhibits bacterial growth after the seal is broken. Once you puncture the rubber stopper of a saline vial and draw some out, the remaining contents are exposed to whatever microorganisms were on your needle, on the stopper surface, or in the ambient air that entered the vial to replace the withdrawn volume.

United States Pharmacopeia (USP) standards specify that preservative-free sterile solutions should be used within 24 hours at room temperature or discarded. Some institutional guidelines extend this to 7 days under continuous refrigeration, but even that is optimistic for a multi-dose peptide vial that will be punctured repeatedly over weeks. The 7-day figure assumes a single puncture in a controlled pharmacy environment — not repeated needle insertions in a home setting.

Bacteriostatic water is a fundamentally different product. It is water for injection containing 0.9% benzyl alcohol as a bacteriostatic preservative. Benzyl alcohol is a broad-spectrum antimicrobial agent that inhibits bacterial proliferation by disrupting cell membrane integrity. It does not sterilize — it will not kill a massive bacterial inoculum — but it prevents the low-level contamination introduced by normal vial use from proliferating into a dangerous colony count.

The practical difference is shelf life. A peptide reconstituted in bacteriostatic water and stored at 2-8°C is typically stable and microbiologically safe for 28 to 30 days. The same peptide reconstituted in normal saline should be discarded within 24 hours at room temperature, or within 7 days refrigerated at the absolute outside. For anyone using a multi-dose vial over the course of several weeks — which is the standard use pattern for compounded GLP-1 peptides — saline is not a viable reconstitution vehicle.

There is a third option that occasionally causes confusion: sterile water for injection (SWFI). This is purified water with no sodium chloride and no preservative. It is hypotonic (lower osmolarity than body fluids), which means it can cause hemolysis and pain at the injection site if used in large volumes. More relevantly for reconstitution purposes, it has the same preservative-free limitation as saline — single use only, 24-hour stability, no antimicrobial protection. There is no practical advantage to SWFI over bacteriostatic water for multi-dose peptide vials. Use BAC water.

Several nuances deserve attention.

pH compatibility. GLP-1 peptides like semaglutide analogs are typically formulated to be stable at pH 7.4 to 8.0. Bacteriostatic water has a pH range of approximately 4.5 to 7.0, depending on the manufacturer and lot. Most peptides tolerate this range without issue, but some formulations may exhibit transient turbidity when BAC water is first added — this usually clears within a few minutes of gentle swirling as the solution equilibrates. If the turbidity persists, if you see visible particles that do not dissolve, or if the solution remains noticeably cloudy after five minutes, that is a stability problem. Do not inject a turbid solution. Discard the vial and start over with a fresh one.

Benzyl alcohol and neonates. You may encounter warnings that bacteriostatic water should not be used in neonates or premature infants. This is correct — benzyl alcohol is metabolized to benzoic acid, and neonates (particularly preterm infants) have immature hepatic conjugation pathways that cannot clear benzoic acid efficiently. Accumulation causes “gasping syndrome,” a serious and potentially fatal toxicity. This contraindication is specific to neonates. It is not relevant to adult GLP-1 users. If you see a warning label on BAC water about neonatal use, that is not a signal to avoid it — it is a regulatory requirement for a product that could theoretically be used in a neonatal setting. It does not apply to you.

Source quality. Not all bacteriostatic water is equivalent. What you want: USP-grade bacteriostatic water, manufactured in an FDA-registered facility, sealed in individual glass vials (typically 10mL or 30mL), with a clear lot number and expiration date printed on the label. The vial should have a National Drug Code (NDC) number. Hospira (now Pfizer) and Fresenius Kabi are the most common manufacturers of pharmaceutical-grade BAC water in the US market.

What you should avoid: bacteriostatic water sold by random Amazon marketplace sellers with no NDC number, no lot number, and no clear manufacturer. BAC water sold in plastic bottles. BAC water without an expiration date. Any product where you cannot trace the manufacturing chain. The benzyl alcohol concentration needs to be exactly 0.9% — too little and you lose bacteriostatic efficacy, too much and you risk local tissue irritation at the injection site. Pharmaceutical manufacturers control this precisely. Unknown sellers may not.

The rule is simple: use bacteriostatic water from a verifiable pharmaceutical source for every reconstitution. No exceptions. The cost difference between pharmaceutical-grade BAC water and questionable-source BAC water is a few dollars per vial. The cost difference between a clean reconstitution and a contaminated one is an emergency room visit.

Mistake 2: Shaking the vial

This seems trivial. It is not. The instinct to shake a vial when you want something to dissolve is deeply ingrained — you shake a bottle of salad dressing, you shake a protein shake, you shake a snow globe. The physical intuition is that vigorous agitation accelerates dissolution. For peptides, vigorous agitation accelerates destruction.

The problem is the air-water interface. When you shake a vial containing liquid, you create foam. Foam is a dispersion of air bubbles in liquid, and each bubble surface is an air-water interface. At these interfaces, something specific happens to peptide molecules: they undergo surface denaturation. Peptide and protein molecules have hydrophobic regions (amino acid side chains that are energetically unfavorable in water) and hydrophilic regions (side chains that interact favorably with water). In their native conformation in solution, the hydrophobic regions are typically buried in the interior of the molecule’s fold, shielded from water. At an air-water interface, the energy landscape changes — the air phase is hydrophobic, so the molecule reorients to expose its hydrophobic regions to the air side. This reorientation unfolds the peptide from its native structure.

For large proteins (antibodies, enzymes, 50-150 kDa molecules), this surface denaturation is catastrophic and irreversible. The unfolded molecules aggregate into visible particles and precipitate out of solution. This is why biologic drug manufacturers spend enormous effort engineering formulations that minimize surface denaturation during shipping and handling.

For smaller peptides like GLP-1 analogs (semaglutide is approximately 4.1 kDa), the damage is less dramatic but still real. These peptides have less complex tertiary structure to lose, but they can still undergo conformational changes at the air-water interface that reduce biological activity. More importantly, the mechanical shearing forces in vigorous shaking can break peptide bonds directly — not through the surface denaturation mechanism, but through simple physical force on dissolved molecules. The result is fragmented peptides with reduced or absent bioavailability, and the formation of particulate matter that should not be injected.

The correct reconstitution technique is methodical and unhurried.

First, remove the flip-top cap from the peptide vial and swab the rubber stopper with a 70% isopropyl alcohol wipe. Let it air dry for a few seconds. Draw your measured volume of bacteriostatic water into a syringe. Insert the needle through the rubber stopper at a slight angle.

Here is where technique matters: do not inject the BAC water directly onto the lyophilized powder. Aim the needle tip at the inside wall of the glass vial and depress the plunger slowly. Let the water run down the glass wall and pool at the bottom, where it will contact the powder gently. This slow addition avoids the localized denaturation that occurs when a stream of liquid hits dry peptide at high velocity — the sudden hydration of concentrated peptide at the impact point can create localized pH and concentration extremes that damage the molecules before they have a chance to dissolve uniformly.

Once all the BAC water has been added, withdraw the needle. Now, gently swirl the vial using a slow rotational motion — think of drawing small circles in the air with the vial held between your thumb and forefinger. No wrist-snapping. No vigorous circular agitation. Alternatively, roll the vial gently between your palms. The goal is to create laminar flow within the liquid — smooth, even movement that brings solvent into contact with powder without creating turbulence, foam, or significant air-water interface.

Be patient. Some lyophilized peptides dissolve within 30 seconds. Others, particularly those with higher concentrations or different lyoprotectant formulations, may take two to five minutes to fully dissolve. If you are using cold BAC water (straight from the refrigerator), dissolution will be slower — the solubility of most peptides increases with temperature, so cold solvent takes longer. You can let the BAC water reach room temperature before reconstitution to speed this up, but do not heat it. Room temperature is fine. Body temperature is fine. Warm water from a tap is too much.

A correctly reconstituted solution should be clear and colorless, or very faintly yellow for certain peptides. Hold the vial up to a light source and examine it. You should be able to see clearly through the solution. There should be no visible particles floating in the liquid. There should be no persistent cloudiness or opalescence. Transient swirling during active dissolution is normal — persistent turbidity after five minutes of gentle swirling is not.

When to discard: visible particles that do not dissolve with continued gentle swirling. Significant and persistent turbidity. Any color change — brown, pink, dark yellow. Visible fibers or foreign matter. If in doubt, discard the vial and reconstitute a new one. The cost of a single peptide vial is trivial compared to the cost of injecting a degraded or contaminated solution. This is not a place to be economical.

Mistake 3: Wrong storage temperature

Temperature management for peptides is not complicated, but it requires understanding that the rules change depending on the physical state of the peptide. There are three states, and each has its own temperature requirements.

State 1: Lyophilized powder, sealed, unused. This is the most stable state. The peptide is dry, protected by its lyoprotectant matrix, and sealed under vacuum or inert gas in the original vial. For long-term storage (months to years), keep lyophilized peptides at -20°C in a standard freezer. For medium-term storage (weeks to a few months), a refrigerator at 2-8°C is perfectly adequate. Room temperature (20-25°C) is acceptable for days to a few weeks, but degradation is measurably faster — this is fine for transit or short-term holding, not for stockpiling. The enemy of lyophilized peptides is heat and moisture. A vial left in a hot car, on a sunny windowsill, or in a humid bathroom cabinet is losing potency. Peptide bonds may not hydrolyze in the absence of water, but other degradation pathways — deamidation, oxidation — proceed faster at elevated temperatures even in the dry state.

State 2: Reconstituted in bacteriostatic water, stored between uses. This is where most errors occur. Once reconstituted, the peptide must be refrigerated at 2-8°C. Not “cool.” Not “room temperature.” Refrigerator. The 28-30 day stability window for BAC water reconstitution assumes continuous refrigeration at 2-8°C. At room temperature, both microbial growth and chemical degradation accelerate dramatically — the benzyl alcohol in BAC water is bacteriostatic, not bactericidal, and its efficacy is temperature-dependent. At 25°C, bacterial doubling times are measured in hours. At 4°C, they are measured in days. The preservative buys you time; refrigeration buys you much more time. Together, they give you the 28-30 day window.

Where in the refrigerator matters. The door shelf is the worst location — every time the door opens, the temperature on those shelves swings by several degrees. The back of the main compartment, where temperature is most stable, is optimal. Ideally, keep the vial upright in a small container or bag to prevent it from rolling around and potentially cracking.

State 3: Reconstituted, in-use vial during dosing. When you take the vial out to draw a dose, you are introducing a temperature excursion. This is unavoidable and, in reasonable amounts, not a problem. Draw your dose and return the vial to the refrigerator promptly. Do not leave a reconstituted vial sitting on your bathroom counter for hours between doses. Do not carry it in your pocket all day. Do not leave it in a car. Every minute at room temperature is cumulative degradation that shortens the effective life of the vial.

The freezing error. This is surprisingly common. The reasoning sounds logical: if cold is good for stability, colder must be better. If the vial will last 28 days in the refrigerator, surely it will last longer in the freezer. This reasoning is wrong, and the mistake is irreversible.

When an aqueous solution freezes, ice crystals form. These crystals are pure water — as water molecules organize into the crystalline ice lattice, they exclude solutes, including the peptide molecules. The peptide becomes concentrated in ever-shrinking pockets of unfrozen liquid between growing ice crystals. This cryoconcentration subjects the peptide to extreme local concentration, pH shifts (as buffer components crystallize at different rates), and mechanical shearing forces as expanding ice crystals physically deform the surrounding liquid.

For GLP-1 analogs, freeze-thaw degradation is well-documented. The mechanical forces of ice crystallization break intramolecular bonds, disrupt whatever secondary structure the peptide maintains in solution, and cause irreversible aggregation. A vial of reconstituted semaglutide analog that has been frozen and thawed will contain a mixture of intact peptide, fragmented peptide, and aggregated particulates. The bioavailability is unpredictable. Discard it.

This is qualitatively different from lyophilization, even though both processes involve freezing. Lyophilization uses controlled freezing rates, lyoprotectant excipients, and vacuum sublimation specifically engineered to protect the peptide during the phase transition. Throwing a reconstituted vial in your home freezer has none of these protections.

Temperature recovery. If a reconstituted vial briefly reaches room temperature — you left it on the counter for an hour, forgot to put it back after your morning dose — it is likely still viable. A single brief excursion to 20-25°C for an hour or two does not destroy the peptide. But each excursion is cumulative degradation. There is no good published data on exact thresholds for compounded GLP-1 peptides, but the conservative guidance based on general peptide stability data is this: each room-temperature excursion of one to two hours costs you roughly one to two days of your 28-day stability window. Multiple excursions add up. If a vial has been in and out of the refrigerator repeatedly, or left out overnight even once, shorten your use window accordingly. The safest practice is to date the vial at the time of reconstitution, discard it at 28 days regardless of remaining volume, and treat any significant temperature excursion as a reason to discard sooner.

Mistake 4: Not checking vial integrity

This is the mistake people do not think to make, which is exactly why it matters. Everyone focuses on the reconstitution process itself — the liquid, the mixing technique, the storage. Few people examine the vial before they start. But vial integrity is the foundation that everything else depends on. A compromised vial can undermine a perfect reconstitution protocol.

What to check before reconstitution:

The rubber stopper. Look at it carefully before you swab it with alcohol. The stopper should be smooth, intact, and properly seated in the vial neck. Look for core plugs — small fragments of rubber that can be punched out of the stopper during needle insertion, falling into the solution. A stopper that has been punctured multiple times (or punctured with a dull or large-gauge needle) may show visible damage: small holes, tears, or a roughened surface. If the stopper looks chewed up, the vial has either been accessed multiple times before reaching you (a serious supply chain concern) or the stopper material is degrading. Either way, do not use it.

The aluminum crimp seal. The flip-off cap should remove cleanly, revealing an intact aluminum crimp ring around the stopper. The crimp should be uniform, with no deformation, bending, or evidence of having been removed and reapplied. Any sign of tamper — a crimp that looks pried up, a stopper that sits unevenly — means the sterility of the contents cannot be verified. Discard the vial.

The powder itself. Look through the glass at the lyophilized material. It should be a fine, uniform white or off-white powder, or a porous cake that may have partially collapsed but should still appear dry and consistent in color. Warning signs: discoloration (yellow, brown, or gray tones suggest degradation or contamination), visible clumping or wet spots (indicating moisture intrusion — the vacuum seal failed, ambient moisture entered, and the peptide has begun to degrade in the vial before you even opened it), or an entirely collapsed cake that looks glassy rather than porous (suggesting incomplete lyophilization or temperature excursion during storage).

The vacuum check. This is subtle but informative. A properly sealed lyophilized peptide vial should be under partial vacuum — air was removed during the lyophilization process, and if the seal is intact, the internal pressure should be lower than atmospheric. When you insert your needle through the stopper, you should feel slight resistance from the vacuum pulling the stopper down. Alternatively, when you push the needle through, the plunger of your syringe may pull back slightly as the lower internal pressure draws on it. Easy needle entry with no resistance may indicate a compromised vacuum seal — air has already entered the vial, bringing moisture and potential microbial contamination with it. This is not definitive (some vials are backfilled with inert gas rather than sealed under vacuum), but the presence of vacuum is a reassuring positive sign, and its unexpected absence is worth noting.

The contamination risk people underestimate. Every time a needle passes through a rubber stopper, it creates a small channel. Each puncture introduces a microscopic amount of ambient air and whatever was on the needle surface (including skin flora from the injection site if you are using the same needle to both draw and inject — don’t do this, but some people do). The benzyl alcohol in bacteriostatic water handles this level of contamination comfortably for the first ten to fifteen punctures.

But consider the math. If you are using a 5mg vial reconstituted with 2mL of BAC water, and your dose is 250mcg per injection, that is 20 doses per vial. Twenty needle punctures through the same rubber stopper. At puncture fifteen, you are pushing through a stopper that has been perforated fourteen times before. The rubber self-seals to some degree, but its integrity degrades with each puncture. By puncture twenty, the stopper’s ability to maintain a reliable seal against environmental contamination is genuinely diminished.

This is why the 28-30 day discard date exists as a hard cutoff, not a suggestion. Even if the vial still contains usable volume at day 30, the cumulative risk of stopper degradation and repeated contamination exposure means the risk-benefit calculation has shifted. Discard the vial. Open a new one.

Clean technique, every time. Swab the rubber stopper with a 70% isopropyl alcohol wipe before every single needle insertion. Not just the first time. Every time. This is not optional. It is not excessive. It is the minimum standard of clean technique for multi-dose vial use, codified in USP Chapter 797 and practiced in every pharmacy in the country. The alcohol wipe kills surface bacteria that have settled on the stopper since the last access. Skip it once, and you are relying entirely on the benzyl alcohol in the solution to handle whatever you just pushed through the stopper. The benzyl alcohol can handle a lot. Do not test its limits.

Mistake 5: Getting the dilution math wrong

This is where the most dangerous reconstitution errors occur. Mistakes 1 through 4 reduce peptide efficacy or introduce contamination risk — serious problems, but problems that manifest gradually. A dilution math error can result in injecting ten times the intended dose in a single administration. The consequences are immediate, dose-dependent, and potentially severe: profound nausea, vomiting, hypoglycemia, and in extreme cases, pancreatitis.

The math itself is not difficult. But it involves units of measurement that most people do not work with routinely, and it is performed in a context (about to inject yourself) where anxiety can degrade attention to detail. This section walks through the calculation more slowly and more thoroughly than any vendor guide will, because getting it right matters more than getting it done quickly.

The core formula.

The goal is to determine how many micrograms of peptide are contained in each “unit” marking on a U-100 insulin syringe. Once you know this, you can calculate exactly how many units to draw for any desired dose.

The formula:

mcg per unit = (mg of peptide in vial x 1000) / (mL of BAC water added x 100)

The “x 1000” converts milligrams to micrograms. The “x 100” accounts for the fact that a U-100 insulin syringe has 100 unit markings per 1mL of volume.

Worked example 1: You have a 5mg vial of peptide. You add 1mL of bacteriostatic water.

mcg per unit = (5 x 1000) / (1 x 100) = 5000 / 100 = 50 mcg per unit

Every tick mark on your U-100 syringe now represents 50 micrograms of peptide. To inject 250mcg, you would draw to the 5-unit mark (250 / 50 = 5 units).

Worked example 2: You have a 5mg vial of peptide. You add 2mL of bacteriostatic water.

mcg per unit = (5 x 1000) / (2 x 100) = 5000 / 200 = 25 mcg per unit

Every tick mark represents 25 micrograms. To inject 250mcg, you would draw to the 10-unit mark (250 / 25 = 10 units). Notice that you are drawing twice the volume for the same dose — because you diluted the peptide into twice as much liquid.

Worked example 3: You have a 10mg vial of peptide. You add 2mL of bacteriostatic water.

mcg per unit = (10 x 1000) / (2 x 100) = 10000 / 200 = 50 mcg per unit

Same concentration as Example 1, but with twice the peptide and twice the liquid. To inject 500mcg, you would draw to 10 units (500 / 50 = 10 units).

The critical confusion: units versus milliliters.

This is where people get hurt. A U-100 insulin syringe is calibrated so that 100 units equals 1 milliliter. Each small graduation mark on the syringe barrel represents 1 unit, which is 0.01mL. The syringe markings say “units” — they do not say “mL.”

The danger arises when someone confuses the two scales. If your calculation tells you to inject “10 units” and you mistakenly interpret that as “0.1 units” or “10mL,” you are in trouble. Ten milliliters is the entire volume of a standard BAC water vial — no one can accidentally inject 10mL from a 1mL insulin syringe, so that specific error is physically prevented by the syringe capacity. But there are subtler versions of this confusion.

For instance: you calculate that you need 0.1mL for your dose. You look at your U-100 syringe and see the marking “10” — which represents 10 units, which is 0.1mL. Correct. But if you have a syringe that is marked in 2-unit increments (common for 0.5mL syringes), the “10” marking means the same thing but looks different. And if you are using a 0.3mL syringe (30-unit), the graduations are physically closer together, and misreading by a few units is easier than you might expect, especially in poor lighting or without reading glasses.

The safest practice: after completing your calculation, express the result in units on your specific syringe. Write it down. Say it out loud. Verify it makes intuitive sense. If your calculation tells you to draw to 50 units for a 250mcg dose, and you know the vial contains 5mg total in 2mL, then 50 units is 0.5mL, which is one quarter of the total vial volume. A 250mcg dose is 5% of the total 5mg in the vial. One quarter of the volume for 5% of the peptide does not make sense — that should trigger a recalculation. (The correct answer would be 10 units, not 50.) Building this kind of sanity check into your process catches errors before they reach a needle.

The BAC water volume decision.

How much bacteriostatic water to add is not arbitrary, but there is a range of acceptable choices, and the right one depends on your dosing needs.

More BAC water means a lower concentration per unit. This makes it easier to measure small doses precisely — if each unit is 25mcg instead of 50mcg, the difference between 4 and 5 units on the syringe is 25mcg instead of 50mcg, giving you finer dosing resolution. The tradeoff is larger injection volumes, which some users find uncomfortable.

Less BAC water means a higher concentration per unit. Smaller injection volumes, but harder to measure small doses precisely. The difference between 4 and 5 units on the syringe now represents 50mcg, so you cannot hit a dose target between those values.

For most compounded GLP-1 protocols, the practical range is 1mL to 2mL of BAC water per vial. Some general guidance:

If your typical dose is above 200mcg per injection, 1mL gives manageable injection volumes (a 250mcg dose from a 5mg/1mL reconstitution is 5 units = 0.05mL, which is a very small and comfortable injection). Using 2mL would still work (10 units = 0.1mL), just a slightly larger volume for the same dose.

If your typical dose is below 100mcg per injection (common during titration or with more potent analogs), 2mL gives better precision. A 50mcg dose from a 5mg/2mL reconstitution is 2 units — barely legible on many syringes, and a half-unit misread means a 25% dosing error. Consider using 2.5mL or even 3mL of BAC water if you need very fine dosing control at low mcg ranges, accepting the larger injection volume as a worthwhile tradeoff for accuracy. Note that using more than 2mL of BAC water per standard 3mL or 5mL peptide vial is mechanically feasible but reduces the headspace in the vial, which can affect your ability to draw doses without introducing air bubbles. Balancing dilution precision against vial mechanics is a practical consideration that vendor guides typically do not mention.

Common reconstitution scenarios at a glance:

• 5mg vial + 2mL BAC water = 25 mcg/unit. For 100mcg dose: draw to 4 units. For 250mcg dose: draw to 10 units.
• 5mg vial + 1mL BAC water = 50 mcg/unit. For 100mcg dose: draw to 2 units. For 250mcg dose: draw to 5 units.
• 10mg vial + 2mL BAC water = 50 mcg/unit. For 250mcg dose: draw to 5 units. For 500mcg dose: draw to 10 units.
• 10mg vial + 3mL BAC water = 33.3 mcg/unit. For 100mcg dose: draw to 3 units. For 250mcg dose: draw to 7.5 units (between the 7 and 8 mark).

The tracking error. When reading a syringe, measure from the bottom edge of the plunger’s rubber gasket — the flat end closest to the needle, where the rubber meets the barrel wall. This is the standard reference point for all syringe readings. Do not read from the top of the gasket, the tip of the plunger rod, or the domed surface of the rubber. The difference between reading from the correct and incorrect reference point can be one to two units, which at high concentrations represents a meaningful dosing error.

Write it down. Seriously. When you reconstitute a vial, write on the vial (or on a piece of tape on the vial) the date of reconstitution, the volume of BAC water used, and the resulting concentration in mcg per unit. This takes ten seconds and eliminates the most common source of dosing error: forgetting your reconstitution parameters and guessing wrong three days later. A reconstituted vial without a label is a dosing error waiting to happen.

Building a clean reconstitution workspace

You do not need a laboratory. You do not need a laminar flow hood, an autoclave, or a full sterile field. You are not performing surgery or compounding in a pharmacy cleanroom. What you are performing is a clean technique procedure — a level of aseptic practice that minimizes contamination risk in a non-sterile environment. The distinction matters because the barrier to entry is low: you need a few inexpensive supplies and a clean surface.

What you need:

Alcohol wipes. Individual-packet 70% isopropyl alcohol prep pads, the kind sold at any pharmacy. You will use one to swab the vial stopper before every needle insertion — reconstitution and every subsequent dose draw. Buy them in bulk. They cost almost nothing.

A clean, flat, hard surface. A kitchen counter wiped with isopropyl alcohol works. A clean cutting board works. A desk cleared of clutter works. The surface should be non-porous (not fabric, not paper towel) and recently cleaned. You need a stable surface where you can set down vials, syringes, and alcohol wipes without them rolling or falling.

Proper lighting. You need to see clearly. You are reading small graduation marks on a syringe and inspecting a solution for clarity and particles. Dim bathroom lighting is insufficient. A desk lamp or well-lit kitchen counter is ideal. If you wear reading glasses, wear them.

Sharps disposal. Every needle you use goes into a sharps container immediately after use. Never recap a needle by hand — the single most common needlestick injury in clinical settings is recapping. Use a one-handed scoop technique if you must recap, but the preferred method is direct disposal into a puncture-resistant sharps container. These are available at any pharmacy for a few dollars.

A tracking system. Whether it is a notepad, a phone app, a spreadsheet, or a piece of tape on the vial, you need to track: the date of reconstitution, the volume of BAC water used, the resulting concentration, and the discard date (28 days from reconstitution). If you are using multiple vials (for example, titrating from a low dose using one vial while an older vial is still in use), labeling becomes even more important. Mixing up two vials with different concentrations is a dosing error.

What you do not need:

Gloves — they provide no meaningful contamination protection for this procedure and can reduce tactile feedback when handling small syringes. Sterile drapes. Face masks (unless you are actively coughing or sneezing, in which case you should not be performing a clean technique procedure until you have stopped). A dedicated “injection room.” The goal is clean, not sterile. Clean technique in a well-lit kitchen is safer than sloppy technique in a bathroom you have designated as your “medical space” because it feels more official.

When to seek help

Most reconstitution and injection complications are minor and self-limiting. Slight redness at the injection site that resolves within a few hours. Mild bruising from a capillary nick. A small, firm lump at the injection site (common with subcutaneous injections, resolves over days). These are normal and do not require medical attention.

The following signs are not normal and require prompt medical evaluation:

Injection site infection. Redness that extends more than 2 centimeters from the injection point. Redness that is expanding over hours rather than resolving. Warmth and tenderness at the site that worsens rather than improves. Any visible pus or drainage. A red streak extending from the injection site toward the nearest lymph node chain. These are signs of cellulitis or abscess formation — bacterial infection of the skin and subcutaneous tissue. This is treatable with antibiotics, but it requires a physician’s evaluation. Do not attempt to treat it yourself. Do not “wait and see” if it gets worse overnight.

Systemic infection signs. Fever above 100.4°F (38°C) within 24 to 48 hours of injection. Chills. Malaise. Flu-like symptoms. These can indicate that bacteria from a contaminated vial or contaminated injection technique have entered the bloodstream. This is rare but serious. Seek medical attention the same day.

Allergic reaction. Hives, generalized itching, swelling of the face or throat, difficulty breathing. Extremely rare with GLP-1 peptides, but benzyl alcohol in BAC water can cause allergic reactions in sensitized individuals. If you experience any respiratory difficulty, call emergency services.

The critical distinction: GLP-1 side effects (nausea, reduced appetite, mild fatigue) are expected and well-characterized. Infection signs (fever, expanding redness, drainage) are not GLP-1 side effects. If you are experiencing symptoms that do not match the known pharmacological profile of the peptide, consider the possibility that you have a reconstitution or contamination problem, not a peptide side effect.

When in doubt, discard the vial and consult a physician. Peptides can be replaced for a few dollars. Your health cannot.

The information you will not get from vendors

Return to the structural problem described at the beginning of this article. The peptide reconstitution information ecosystem is dominated by parties with direct commercial interests. The vendor who sells you the peptide also sells the BAC water, the syringes, the alcohol wipes, and the sharps containers. Their reconstitution tutorial is a component of their sales funnel. Their incentive is to make you feel confident enough to buy — not cautious enough to discard a questionable vial.

This does not mean vendor-published information is wrong. Much of it is accurate. But notice what it omits. Vendor tutorials rarely emphasize the 28-day hard discard date — because a vial discarded at day 28 with remaining volume is a vial you need to reorder, and framing reconstitution around strict timelines might make the cost per dose seem higher. Vendor tutorials gloss over stopper degradation from repeated punctures — because acknowledging that a vial should not be punctured more than fifteen to twenty times complicates the math for high-dose users who might get more doses from a single vial. Vendor tutorials present dilution math as simpler than it is — because dwelling on the possibility of a tenfold dosing error is not conducive to a purchase decision.

The information gap is not malice. It is incentive alignment. Vendors are optimizing for conversion. We are optimizing for your safety. These are sometimes the same thing, but not always, and the places where they diverge are exactly the places where mistakes happen.

If you are sourcing compounded GLP-1 peptides, choose a supplier that publishes certificates of analysis (COAs) for each lot — third-party HPLC purity testing, endotoxin testing, and sterility testing. A supplier that publishes COAs is accepting transparency as a cost of doing business, which tells you something about their priorities. cmpd.health is one example of a supplier that maintains this standard. There are others. The COA is the evidence. The marketing copy is not.

We wrote this guide because the information should exist in a form that is not attached to a shopping cart. Whether you found it useful is between you and your next reconstitution. Do it carefully. Do it correctly. Label the vial. Refrigerate it. Throw it away at 28 days. The peptide is the cheap part. Getting it right is the part that matters.